Pricing Log in Create free account
Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue
+10.9%
EPS
−351.9%
Free cash flow
−11.5%
Total debt
+3.28%

Quarter to September 2026, against a year earlier

169.01 9.19 −5.16%
Market cap
$10.8B
P/E
0.0×
Fwd P/E
−615×
Dividend yield
—
F-score
6/9
Altman Z
7.49
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Repligen Corporation (RGEN) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Repligen Corporation (RGEN) trades at a EV/EBITDA of 60.1×. Over the past ten years it has ranged from 30.1× (January 2023) to 191× (January 2025); the current reading is higher than 47% of that period. That is above the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 60.2× (61.76%)
FY2024 157× 90.21%
FY2023 82.7× 161.49%
FY2022 31.6× (52.03%)
FY2021 65.9× (26.09%)
FY2020 89.2× 37.94%
FY2019 64.7× 28.38%
FY2018 50.4× (14.28%)
FY2017 58.8× 25.32%
FY2016 46.9× 0.29%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 68.6× 47.11%
Jun 2026 46.6× 16.22%
Mar 2026 40.1× (33.32%)
Dec 2025 60.2× (23.13%)
43 more quarters

Against its own ten years

Low 30.1× High 191×
Ten-year median 62.5×
Current reading's percentile 47

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation compare 7.6×
ALGN Align Technology, Inc. compare 12.6×
BAX Baxter International Inc. compare 13.2×
ATR AptarGroup, Inc. compare 13.2×
BLCO Bausch + Lomb Corporation compare 14.6×
AVTR Avantor, Inc. compare 14.7×
COO The Cooper Companies, Inc. compare 15.8×
TFX Teleflex Incorporated compare 35.7×
RGEN Repligen Corporation 60.1×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on RGEN